Memory, fluency, and orientation: A five-minute screening test for cognitive decline

被引:13
作者
Delgado Derio, C. [1 ,2 ]
Guerrero Bonnet, S. [1 ]
Troncoso Ponce, M. [3 ]
Araneda Yanez, A. [3 ]
Slachevsky Chonchol, A. [4 ,5 ,6 ,7 ]
Behrens Pellegrino, M. I. [1 ,7 ]
机构
[1] Univ Chile, Hosp Clin, Dept Neurol & Neurocirugia, Santiago, Chile
[2] Univ Chile, Hosp Clin, Direcc Invest Clin, Santiago, Chile
[3] Univ Chile, Fac Med, Santiago 7, Chile
[4] Univ Chile, Fac Med, ICBM, Santiago 7, Chile
[5] Univ Chile, Fac Med, Dept Ciencias Neurol Oriente, Santiago 7, Chile
[6] Hosp Salvador, Serv Neurol, Unidad Neurol Cognit & Demencias, Santiago, Chile
[7] Clin Alemana Santiago, Santiago, Chile
来源
NEUROLOGIA | 2013年 / 28卷 / 07期
关键词
Cognitive impairment screening; Chile; Dementia; Spanish; MINI-MENTAL STATE; INFORMANT INTERVIEW; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; DEMENTIA; IMPAIRMENT; VALIDITY; BATTERY; MOCA;
D O I
10.1016/j.nrl.2012.10.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The prevalence of cognitive impairment (CI) will double in the next 20 years, making early detection a key priority. Objectives: Validation of a 5-minute CI screening test. Methods: Adults aged 60 and older were recruited from memory clinics and the community at large in the Santiago, Chile metropolitan area. Based on clinical examination they were categorised as No CI (NCI), Mild CI (MCI) and dementia sufferers (DS). We measured the validity of a new test, MEFO, evaluating memory (5 points), phonetic verbal fluency (2 points) and orientation (6 points) by comparing its results with those from the MMSE. Results: We evaluated 214 subjects, comprising 49 with dementia, 47 with MCI, and 118 with no Cl. The MEFO differentiated between all 3 groups whereas the MMSE did not discriminate between the MCI and NCI groups. The area under the ROC curve (AUC) for the MEFO distinguishing NCI subjects from dementia sufferers was 0.97; for NCI vs CI (dementia + MCI), 0.89; and for NCI vs MCI, 0.80. On the MMSE these values were 0.95, 0.84, and 0.73, respectively. A cut-off score of 6/7 on the MEFO identified dementia sufferers with a sensitivity of 86% and a specificity of 96%. A cut-off score of 8/9 distinguished CI from NCI subjects with a sensitivity of 83% and a specificity of 75%. Conclusions: The MEFO is a valid and reliable test for discriminating between dementia and CI sufferers and subjects with no Cl. Its validity is similar to that the MMSE under these conditions, but it is more effective for identifying subjects with MCI and its administration time is shorter. (c) 2012 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:400 / 407
页数:8
相关论文
共 42 条
[1]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[2]   CROSS-NATIONAL INTERRATER AGREEMENT ON THE CLINICAL DIAGNOSTIC-CRITERIA FOR DEMENTIA [J].
BALDERESCHI, M ;
AMATO, MP ;
NENCINI, P ;
PRACUCCI, G ;
LIPPI, A ;
AMADUCCI, L ;
GAUTHIER, S ;
BEATTY, L ;
QUIROGA, P ;
KLASSEN, G ;
GALEA, A ;
MUSCAT, P ;
OSUNTOKUN, B ;
OGUNNIYI, A ;
PORTERASANCHEZ, A ;
BERMEJO, F ;
HENDRIE, H ;
BURDINE, V ;
BRASHEAR, A ;
FARLOW, M ;
MAGGI, S ;
KATZMAN, R .
NEUROLOGY, 1994, 44 (02) :239-242
[3]   Clinical validity of the 'mini-mental state' for Spanish speaking communities [J].
Blesa, R ;
Pujol, M ;
Aguilar, M ;
Santacruz, P ;
Bertran-Serra, I ;
Hernández, G ;
Sol, JM ;
Peña-Casanova, J .
NEUROPSYCHOLOGIA, 2001, 39 (11) :1150-1157
[4]  
Böhm P, 2005, NEUROLOGIA, V20, P402
[5]  
Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO
[6]  
2-6
[7]   Screening for dementia with the memory impairment screen [J].
Buschke, H ;
Kuslansky, G ;
Katz, M ;
Stewart, WF ;
Sliwinski, MJ ;
Eckholdt, HM ;
Lipton, RB .
NEUROLOGY, 1999, 52 (02) :231-238
[8]   A proposal for the application and scoring of the Clock Drawing Test in Alzheimer's disease [J].
Cacho, J ;
García-García, R ;
Arcaya, J ;
Vicente, JL ;
Lantada, N .
REVISTA DE NEUROLOGIA, 1999, 28 (07) :648-655
[9]   Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia [J].
Canning, SJD ;
Leach, L ;
Stuss, D ;
Ngo, L ;
Black, SE .
NEUROLOGY, 2004, 62 (04) :556-562
[10]  
Carnero-Pardo C, 2007, NEUROLOGIA, V22, P860